The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Tsygankova P.G.

FGBU "Mediko-geneticheskiĭ nauchnyĭ tsentr RAMN"

Mikhaĭlova S.V.

Rossiĭskaia detskaia klinicheskaia bol'nitsa (RDKB), Moskva

Zakharova E.Iu.

Mediko-geneticheskiĭ tsentr RAMN

Pichkur N.A.

Tsentr metabolicheskikh zabolevaniĭ natsional'noĭ detskoĭ spetsializirovannoĭ bol'nitsy (OKhMADET), Kiev, Ukraina

Il'ina E.S.

Rossiĭskaia detskaia klinicheskaia bol'nitsa (RDKB), Moskva

Nikolaeva E.A.

Sechenov First Moscow State Medical University, Moscow, Russia

Rudenskaia G.E.

Mediko-geneticheskiĭ nauchnyĭ tsentr RAMN

Dadali E.L.

FGBU Mediko-geneticheskiĭ nauchnyĭ tsentr RAMN, Moskva

Kolpakchi L.M.

Rossiĭskaia detskaia klinicheskaia bol'nitsa (RDKB), Moskva

Fedoniuk I.D.

Rossiĭskaia detskaia klinicheskaia bol'nitsa (RDKB), Moskva

Matiushchenko G.N.

Mediko-geneticheskiĭ nauchnyĭ tsentr RAMN

Syndrome Leigh caused by mutations in the SURF1 gene: clinical and molecular-genetic characteristics

Authors:

Tsygankova P.G., Mikhaĭlova S.V., Zakharova E.Iu., Pichkur N.A., Il'ina E.S., Nikolaeva E.A., Rudenskaia G.E., Dadali E.L., Kolpakchi L.M., Fedoniuk I.D., Matiushchenko G.N.

More about the authors

Read: 31495 times


To cite this article:

Tsygankova PG, Mikhaĭlova SV, Zakharova EIu, et al. Syndrome Leigh caused by mutations in the SURF1 gene: clinical and molecular-genetic characteristics. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(1):25‑32. (In Russ.)

Recommended articles:
FA2H gene-associated spastic para­plegia (SPG35) — fami­lial case with late onset. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):137-144
MR imaging of cyto­toxic lesion of the corpus callosum during pneumonia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):140-144
Factors and features of the deve­lopment of epilepsy in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):18-27

References:

  1. Kozlova S.I., Demikova N.S. Nasledstvennye sindromy i mediko-geneticheskoe konsul'tirovanie. Atlas spravochnik. 3-e izd., pererab. i dopol. M: T-vo nauchnykh izdanii KMK; Avtorskaya akademiya 2007; 448.
  2. Krasnopol'skaya K.D. Nasledstvennye bolezni obmena veshchestv. Spravochnoe posobie dlya vrachei. M 2005; 364.
  3. Temin P.A., Kazantseva L.Z. Nasledstvennye narusheniya nervno-psikhicheskogo razvitiya detei. M: Meditsina 2001; 428.
  4. Fenichel Dzheral'd M. Pediatricheskaya nevrologiya. Osnovy klinicheskoi diagnostiki: per. s angl. M: Meditsina 2004; 640.
  5. Benit P., Slama A., Cartault F. et al. Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome. J Med Genet 2004; 41: 14-17.
  6. Bourgeron T., Rustin P., Chretien D. et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nature Genet 1995; 11: 144-149.
  7. Cooper J., Itokawa Y., Pincus J. Thiamine triphosphate deficiency in subacute necrotizing encephalomyelopathy. Science 1969; 164: 74-75.
  8. Cooper J., Pincus J., Itokawa Y. et al. Experience with phosphoryl transferase inhibition in subacute necrotizing encephalomyelopathy. New Eng J Med 1970; 283: 793-795.
  9. Dahl H. Getting to the nucleus of mitochondrial disorders: identification of respiratory chain-enzyme genes causing Leigh syndrome. Am J Hum Genet 1998; 63: 1594-1597.
  10. DiMauro S., De Vivo D. Genetic heterogeneity in Leigh syndrome. (Letter) Ann Neurol 1996; 40: 5-7.
  11. Piekutowska-Abramczuk D., Popowska E., Pronicki M. et al. High prevalence of SURF1c.845-846delCT mutation in Polish Leigh patients. Eur J Paediat Neurol 2008 v pechati.
  12. Gilbert E., Arya S., Chun R. Leigh's necrotizing encephalopathy with pyruvate carboxylase deficiency. Arch Path Lab Med 1983; 107: 162-166.
  13. Gilles L., Raymond D. Neurology of Herediatary Metabolic Diseases of Children, 2nd ed. New York 1996; 379.
  14. Gordon N., Marsden H., Lewis D. Subacute necrotizing encephalomyelopathy in three siblings. Dev Med Child Neurol 1974; 16: 64-78.
  15. Head R., Brown R., Brown G. Diagnostic difficulties with common SURF1 mutations in patients with cytochrome oxidase-deficient Leigh syndrome. J Inherit Metab Dis 2004; 27: 57-65.
  16. Hommes F., Polman H., Reerink J. Leigh's encephalomyelopathy: an inborn error of gluconeogenesis. Arch Dis Child 1968; 43: 423-426.
  17. Kustermann-Kuhn B., Harzer K., Schroder R. et al. Pyruvate dehydrogenase activity is not deficient in the brain of three autopsied cases with Leigh disease (subacute necrotizing encephalomyelopathy, SNE). Hum Genet 1984; 68: 51-53.
  18. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiat 1951; 14: 216-221.
  19. Loeffen J., Smeitink J., Triepels R. et al. The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. Am J Hum Genet 1998; 63: 1598-1608.
  20. Luft R., Ikkos D., Palmieri G. et al. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 1962; 41: 1776-1804.
  21. Menkes J.H. Textbook of Child Neurology, 3 nd Ed. Philadelphia Lea & Febiger 1985; 827.
  22. Ogawa Y., Naito E., Ito M. et al. Three novel SURF-1 mutations in Japanese patients with Leigh syndrome. Pediat Neurol 2002; 26: 3: 196-200.
  23. Pecina P., Gnaiger E., Zeman J. et al. Decreased affinity for oxygen of cytochrome-c oxidase in Leigh syndrome caused by SURF1 mutations. Am J Physiol Cell Physiol 2004; 287: 1384-1388.
  24. Rahman S., Blok R., Dahl H. et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 1996; 39: 343-351.
  25. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill (pub.) (8th ed.) 2001; 6338.
  26. Tiranti V., Jaksch M., Hofmann S. et al. Loss-of-function mutations of SURF-1 are specifically associated with Leigh syndrome with cytochrome-c oxidase deficiency. Ann Neurol 1999; 46: 161-166.
  27. van der Knaap M.S., Valk J. Magnetic Resonance of Myelination and Myelin Disorders. Berlin: Springer Verlag 2005; 1084.
  28. Zhu Z., Yao J., Johns T. et al. SURF1, encoding a factor involved in the biogenesis of cytochrome-c oxidase, is mutated in Leigh syndrome. Nature Genet 1998; 20: 337-343.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.